The role of lipid-protein interactions in amyloid-type protein fibril formation

Chemistry and Physics of Lipids

Volumn 141, Issue 1-2, 2006, Pages 72-82

  Gorbenko, Galyna P ^a   Kinnunen, Paavo K J ^b  

^a V N KARAZIN KHARKIV NATIONAL UNIVERSITY   (Ukraine)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Amyloid fibrils; Membrane induced protein aggregation; Protein lipid interactions

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID PROTEIN; CALCITONIN; LYSOZYME; PREALBUMIN; PRION PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BRAIN SPONGIOSIS; ENZYME KINETICS; FAMILIAL AMYLOIDOSIS; IN VITRO STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN LIPID INTERACTION; PROTEIN STRUCTURE; REVIEW;

AMINO ACID SEQUENCE; AMYLOID; BINDING SITES; LIPID BILAYERS; LIPIDS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY;

EID: 33646557678     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2006.02.006     Document Type: Review

References (118)

1. Ackmann M., Wiech H., and Mandelkow E. Nonsaturable binding indicates clustering of tau on the microtubule surface in a paired helical filament-like conformation. J. Biol. Chem. 275 (2000) 30335-30343
2. Ahmad A., Millett I.S., Doniach S., Uversky V.N., and Fink A.L. Stimulation of insulin fibrillation by urea-induced intermediates. J. Biol. Chem. 279 (2004) 14999-15013
3. Bitan G., Lomakin A., and Teplow D.B. Amyloid β-protein oligomerization. Prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J. Biol. Chem. 276 (2001) 35176-35184
4. Blackley H.K.L., Sanders G.H.W., Davies M.C., Roberts C.J., Tendler S.J.B., and Wilkinson M.J. In-situ atomic force microscopy study of β-amyloid fibrillization. J. Mol. Biol. 298 (2000) 833-840
5. Bokvist M., Lindstrom F., Watts A., and Grobner G. Two types of Alzheimer's β-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. J. Mol. Biol. 335 (2004) 1039-1049
6. Bowie J.U. Membrane proteins: a new method enters the fold. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 3595-3996
7. Butko P., Huang F., Pusztai-Carey M., and Surewicz W.K. Interaction of the δ-endotoxin CytA from Bacillus thuringiensis var. israelensis with lipid membranes. Biochemistry 36 (1997) 12862-12868
8. 28 and C-terminus aliphatic amino acids. Neurochem. Res. 25 (2000) 423-429
9. Chirita C.N., Necula M., and Kuret J. Anionic micelles and vesicles induce tau fibrillization in vitro. J. Biol. Chem. 278 (2003) 25644-25650
10. Chiti F., Stefani M., Taddei N., Ramponi G., and Dobson C.M. Rationalization of the effects of mutations on peptide and protein aggregation rates. Nature 424 (2003) 805-808
11. Choo-Smith L.P., and Surewicz W.K. The interaction between Alzheimer amyloid beta (1-40) peptide and ganglioside GM1-containing membranes. FEBS Lett. 402 (1997) 95-98
12. Choo-Smith L.P., Garson-Rodriges W., Glabe C.G., and Surewicz W.K. Acceleration of amyloid fibril formation by specific binding of Aβ (1-40) peptide to ganglioside-containing model membranes. J. Biol. Chem. 272 (1997) 22987-22990
13. Cohen F.E., and Prusiner S.B. Pathologic conformation of prion proteins. Annu. Rev. Biochem. 67 (1998) 793-819
14. Cole N.B., Murphy D.D., Grider T., Rueter S., Brasaemle D., and Nussbaum R.L. Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein. J. Biol. Chem. 277 (2002) 6344-6352
15. Come J.H., Fraser P.E., and Lansbury P.T. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 5959-5963
16. Davidson W.S., Jonas A., Clayton D.F., and George J.M. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J. Biol. Chem. 273 (1998) 9443-9449
17. Dima R.I., and Thirumalai D. Exploring protein aggregation and self-propagation using lattice models: phase diagram and kinetics. Protein Sci. 11 (2002) 1036-1049
18. Dobson C.M. The structural basis of protein folding and its links with human disease. Philos. Trans. Soc. Lond. Ser. B 356 (2001) 133-145
19. Dobson C.M. Experimental investigation of protein folding and misfolding. Methods 34 (2004) 4-14
20. Dowhan W., Mileykovskaya E., and Bogdanov M. Diversity and versatility of lipid-protein interactions revealed by molecular genetic approaches. Biochim. Biophys. Acta 1666 (2004) 19-39
21. Ege C., and Lee K.Y.C. Insertion of Alzheimer's Aβ-40 peptide into lipid monolayers. Biophys. J. 87 (2004) 1732-1740
22. Eliezer D., Kutluay E., Bussell R., and Browne G. Conformational properties of alpha-synuclein in its free and lipid-associated states. J. Mol. Biol. 307 (2001) 1061-1073
23. Fandrich M., Fletcher M.A., and Dobson C.M. Amyloid fibrils from muscle myoglobin. Nature 410 (2001) 165-166
24. Fernandes F., Loura L.M.S., Prieto M., Koehorst R., Spruijt R.B., and Hemminga M.A. Dependence of M13 major coat protein oligomerization and lateral segregation on bilayer composition. Biophys. J. 85 (2003) 2430-2441
25. Fernandez A., and Berry R.S. Proteins with H-bond packing defects are highly interactive with lipid bilayers: implications for amyloidogenesis. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 2391-2396
26. Fezoui Y., Hartley D.M., Walsh D.M., Selkoe D.J., Osterhout J.J., and Teplow D.B. A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils. Nat. Struct. Biol. 7 (2000) 1095-1099
27. Fink A.L. Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold. Des. 3 (1998) 9-15
28. Fink A.L. Natively unfolded proteins. Curr. Opin. Struct. Biol. 15 (2005) 35-41
29. Friedhoff P., Schneider A., Mandelkow E.M., and Mandelkow E. Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution. Biochemistry 37 (1998) 10223-10230
30. Gamblin T.C., King M.E., Kuret J., Berry R.W., and Binder L.I. Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry 39 (2000) 14203-14210
31. Goedert M., Jakes R., Spillantini M.G., Hasegawa M., Smith M.J., and Crowther R.A. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383 (1996) 550-553
32. Goers J., Uversky V.N., and Fink A.L. Polycation-induced oligomerization and accelerated fibrillation of human α-synuclein in vitro. Protein Sci. 12 (2003) 702-707
33. Hall D., and Minton A.P. Effects of inert volume-excluding macromolecules on protein fiber formation. II. Kinetic models for nucleated fiber growth. Biophys. Chem. 107 (2004) 299-316
34. Han X., and Tamm L.K. pH-Dependent self-association of influenza hemagglutinin fusion peptides in lipid bilayers. J. Mol. Biol. 304 (2000) 953-965
35. Hasegawa M., Crowther R.A., Jakes R., and Goedert M. Alzheimer-like changes in microtubule-associated protein tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation. J. Biol. Chem. 272 (1997) 33118-33124
36. Hurshman A.R., White J.T., Powers E.T., and Kelly J.W. Transthyretin aggregation under partially denaturing conditions is a downhill polymerization. Biochemistry 43 (2004) 7365-7381
37. Jensen M.O., and Mouritsen O.G. Lipids do influence protein function-the hydrophobic matching hypothesis revisited. Biochim. Biophys. Acta 1666 (2004) 205-226
38. Jimenez J.L., Guijarro J.I., Orlova E., Zurdo J., Dobson C.M., Sunde M., and Saibil H.R. Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J. 18 (1999) 815-821
39. Jo E., McLaurin J., Yip C.M., St. George Hyslop P., and Fraser P.E. Synuclein membrane interactions and lipid specificity. J. Biol. Chem. 275 (2000) 34328-34334
40. Jo E., Darabie A.A., Han K., Tandon A., Frazer P.E., and McLaurin J. α-Synuclein-synaptosomal membrane interactions. Implications for fibrillogenesis. Eur. J. Biochem. 271 (2004) 3180-3189
41. Johansson J. Membrane properties and amyloid fibril formation of lung surfactant protein C. Biochem. Soc. Trans. 29 (2001) 601-606
42. Johansson J. Molecular determinants for amyloid fibril formation: lessons from surfactant protein C. Swiss Med. Wkly 133 (2003) 275-282
43. Kayed R., Bernhagen J., Greenfield N., Sweimeh K., Brunner H., Voelter W., and Kapurnioutu A. Conformational transitions of Islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J. Mol. Biol. 287 (1999) 781-795
44. Kazlauskaite J., Sanghera N., Sylvester I., Venien-Bryan C., and Pinheiro T.J.T. Structural changes of the prion protein in lipid membranes leading to aggregation and fibrillization. Biochemistry 42 (2003) 3295-3304
45. Kelly J.W. Mechanisms of amyloidogenesis. Nat. Struct. Biol. 7 (2000) 824-826
46. Khurana R., Ionescu-Zanetti C., Pope M., Li J., Nielson L., Ramirez-Alvarado M., Regan L., Fink A.L., and Carter S.A. A general model for amyloid fibril assembly based on morphological studies using atomic force microscopy. Biophys. J. 85 (2003) 1135-1144
47. King M.E., Ahuja V., Binder L.I., and Kuret J. Ligand-dependent tau filament formation: implications for Alzheimer's disease progression. Biochemistry 38 (1999) 14851-14859
48. Kinnunen P.K.J., Kõiv A., Lehtonen J.Y.A., Rytömaa M., and Mustonen P. Lipid dynamics and peripheral interactions of proteins with membrane surfaces. Chem. Phys. Lipids 73 (1994) 181-207
49. Knight J.D., and Miranker A.D. Phospholipid catalysis of diabetic amyloid assembly. J. Mol. Biol. 341 (2004) 1175-1187
50. Lee A.G. How lipids affect the activities of integral membrane proteins. Biochim. Biophys. Acta 1666 (2004) 62-87
51. Lee H.J., Choi C., and Lee S.J. Membrane-bound α-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J. Biol. Chem. 277 (2002) 671-678
52. Lin H., Bhatia R., and Lal R. Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology. FASEB J. 15 (2001) 2433-2444
53. Lindström F., Bokvist M., Sparrman T., and Gröbner G. Association of amyloid-β peptide with membrane surfaces monitored by solid state NMR. Phys. Chem. Chem. Phys. 4 (2002) 5524-5530
54. Lins L., Flore C., Chapelle L., Talmud P.J., Thomas A., and Brasseur R. Lipid-interacting properties of the N-terminal domain of human apolipoprotein C-III. Protein Eng. 15 (2002) 513-520
55. Lomakin A., Chung D.S., Benedek G.B., Kirschner D.A., and Teplow D.B. On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc. Natl Acad. Sci. U.S.A. 93 (1996) 1125-1129
56. Lomakin A., Teplow D.B., Kirschner D.A., and Benedek G.B. Kinetic theory of fibrillogenesis of amyloid β-protein. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 7942-7947
57. Lundberg K.M., Stenland C.J., Cohen F.E., Prusiner S.B., and Millhauser G.L. Kinetics and mechanism of amyloid formation by the prion protein H1 peptide as determined by time-dependent ESR. Chem. Biol. 4 (1997) 345-355
58. Matsuzaki K., and Horikiri C. Interactions of amyloid β-peptide (1-40) with ganglioside-containing membranes. Biochemistry 38 (1999) 4137-4142
59. McLaurin J., Yang D.S., Yip C.M., and Fraser P.E. Rewiew: modulating factors in amyloid-β fibril formation. J. Struct. Biol. 100 (2000) 259-270
60. Michikawa M., Gong J.-S., Fan Q.-W., Sawamura N., and Yanagisawa K. A novel action of Alzheimer's amyloid β-protein (Aβ): oligomeric Aβ promotes lipid release. J. Neurosci. 21 (2001) 7226-7235
61. Morillas M., Swietnicki W., Gambetti P., and Surewicz W.K. Membrane environment alters the conformational structure of the recombinant human prion protein. J. Biol. Chem. 274 (1999) 36859-36865
62. Muga A., Mantsch H.H., and Surewicz W.K. Membrane binding induces destabilization of cytochrome c structure. Biochemistry 30 (1991) 7219-7224
63. Muga A., Gonzalez-Manas J.M., Lakey J.H., Pattus F., and Surewicz W.K. pH-Dependent stability and membrane interaction of the pore-forming domain of colicin A. J. Biol. Chem. 268 (1993) 1553-1557
64. Munishkina L.A., Fink A.L., and Uversky V.N. Conformational prerequisites for formation of amyloid fibrils from histones. J. Mol. Biol. 342 (2004) 1305-1324
65. Naiki H., and Gejyo F. Kinetic analysis of amyloid fibril formation. Methods Enzymol. 309 (1999) 305-318
66. Naiki H., and Nakakuki K. First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. Lab. Invest. 74 (1996) 374-383
67. Narayanan V., and Scarlata S. Membrane binding and self-association of α-synuclein. Biochemistry 40 (2001) 9927-9934
68. Naslavsky N., Shmeeda H., Friedlander G., Yanai A., Futermani A.H., Barenholz Y., and Taraboulos A. Sphingolipid depletion increases formation of the scrapie prion protein in neuroblastoma cells infected with prions. J. Biol. Chem. 24 (1999) 249-253
69. Necula M., Chirita C.N., and Kuret J. Rapid anionic micelle-mediated α-synuclein fibrillization in vitro. J. Biol. Chem. 278 (2003) 46674-46680
70. Padrick S.B., and Miranker A.D. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry 41 (2002) 4694-4703
71. Pallitto M.M., and Murphy R.M. A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys. J. 81 (2001) 1805-1822
72. Palsdottir H., and Hunte C. Lipids in membrane protein structures. Biochim. Biophys. Acta 1666 (2004) 2-18
73. Paquet M.-J., Laviolette M., Pezolet M., and Auger M. Two-dimensional infrared correlation spectroscopy study of the aggregation of cytochrome c in the presence of dimyristoylphosphatidylglycerol. Biophys. J. 81 (2001) 305-312
74. Pavlov N.A., Cherny D.I., Heim G., Jovin T.M., and Subramaniam V. Amyloid fibrils from the mammalian protein prothymosin. FEBS Lett. 517 (2002) 37-40
75. Perrin R.J., Woods W.S., Clayton D.F., and George J.M. Exposure to long chain polyunsaturated fatty acids triggers rapid multimerization of synucleins. J. Biol. Chem. 276 (2001) 41958-41962
76. Pertinhez T.A., Bouchard M.L., Tomlinson E.J., Wain R., Ferguson S.J., Dobson C.M., and Smith L.J. Amyloid fibril formation by a helical cytochrome. FEBS Lett. 495 (2001) 184-186
77. Pillot T., Goethals M., Vanloo B., Talussot C., Brasseur R., Vandekerckhove J., Rosseneu M., and Lins L. Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide. J. Biol. Chem. 271 (1996) 28757-28765
78. Pillot T., Lins L., Goethals M., Vanloo B., Baert J., Vandekerckhove J., Rosseneu M., and Brasseur R. The 118-135 peptide of the human prion protein forms amyloid fibrils and induces liposome fusion. J. Mol. Biol. 274 (1997) 381-393
79. Pinheiro T.J.T., Elove G.A., Watts A., and Roder H. Structural and kinetic description of cytochrome c unfolding induced by the interaction with lipid vesicles. Biochemistry 36 (1997) 13122-13132
80. Ptitsyn O.B. Molten globule and protein folding. Adv Prot. Chem. 47 (1995) 83-229
81. Raffen R., Dieckman L.J., Szpunar M., Wunschl C., Pokkuluri P.R., Dave P., Wilkins-Stevens P., Cai X., Schiffer M., and Stevens F.J. Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains. Protein Sci. 8 (1999) 509-517
82. Renault A., Lenne P., Zakri C., Aradian A., Vénien-Bryan C., and Amblard F. Surface-induced polymerization of actin. Biophys. J. 76 (1999) 1580-1590
83. Serio T.R., Cashikar A.G., Kowal A.S., Sawicki G.J., Moslehi J.J., Serpell L., Arnsdorf M.F., and Lindquist S.L. Nucleated conformational conversion and the replication of conformational information by a prion determinant. Science 289 (2000) 1317-1321
84. Serpell L.C. Alzheimer's amyloid fibrils: structure and assembly. Biochim. Biophys. Acta 1502 (2000) 16-30
85. Sharp J.S., Forrest J.A., and Jones R.A.L. Surface denaturation and amyloid fibril formation of insulin at model lipid-water interfaces. Biochemistry 41 (2002) 15810-15819
86. Shen C.L., Scott G.L., Merchant F., and Murphy R.M. Light scattering analysis of fibril growth from the amino-terminal fragment β (1-28) of β-amyloid peptide. Biophys. J. 65 (1993) 2383-2395
87. Shin I., Kreimer D., Silman I., and Weiner L. Membrane-promoted unfolding of acetylcholinesterase: a possible mechanism for insertion into the lipid bilayer. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 2848-2852
88. Soto C., and Saborio G.P. Prions: disease propagation and disease therapy by conformational transmission. Trends Mol. Med. 7 (2001) 109-114
89. Sparr E., Engel M.F.M., Sakharov D.V., Sprong M., Jacobs J., de Kruijf B., Hoppener J.W.M., and Killian J.A. Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers. FEBS Lett. 577 (2004) 117-120
90. Srisailam S., Wang H.M., Kumar T.K.S., Rajalingam D., Sivaraja V., Sheu H.S., Chang Y.C., and Yu C. Amyloid-like fibril formation in an all β-barrel protein involves the formation of partially structured intermediate(s). J. Biol. Chem. 277 (2002) 19027-19036
91. Stefani M. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim. Biophys. Acta 1739 (2004) 5-25
92. Sunde M., and Blake C.C.F. From the globular to the fibrous state: protein structure and structural conversion in amyloid formation. Quart. Rev. Biophys. 31 (1998) 1-39
93. Tatulian S.A., Biltonen R.L., and Tamm L.K. Structural changes in a secretory phospholipase A2 induced by membrane binding: a clue to interfacial activation?. J. Mol. Biol. 268 (1997) 809-815
94. Terzi E., Hölzemann G., and Seelig J. Interaction of Alzheimer β-amyloid peptide (1-40) with lipid membranes. Biochemistry 36 (1997) 14845-14852
95. Thirumalai D., Klimov D.K., and Dima R.I. Emerging ideas on the molecular basis of protein and peptide aggregation. Curr. Opin. Struct. Biol. 13 (2003) 1-14
96. Tomski S.J., and Murphy R.M. Kinetics of aggregation of synthetic beta-amyloid peptide. Arch. Biochem. Biophys. 294 (1992) 630-638
97. Träuble H. Membrane electrostatics. In: Abrahamsson S., and Pascher I. (Eds). Structure of Biological Membranes (1977), Plenum Press, New York, London 509-550
98. Trzesniewska K., Brzyska M., and Elbaum D. Neurodegenerative aspects of protein aggregation. Acta Neurobiol. Exp. 64 (2004) 41-52
99. Uversky V.N., and Fink A.L. Conformational constraints for amyloid fibrillation: the importance of being unfolded. Biochim. Biophys. Acta 1698 (2004) 131-153
100. Uversky V.N., Li J., and Fink A.L. Evidence for a partially folded intermediate in alpha-synuclein fibril formation. J. Biol. Chem. 276 (2001) 10737-10744
101. Uversky V.N., Lee H.J., Li J., Fink A.L., and Lee S.J. Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations. J. Biol. Chem. 276 (2001) 43495-43498
102. van Klompenburg W., Nilsson I., von Heijne G., and de Kruijff B. Anionic phospholipids are determinants of membrane protein topology. EMBO J. 16 (1997) 4261-4266
103. Volles M.J., Lee S.J., Rochet J.C., Shtilerman M.D., Ding T.T., Kessler J.C., and Lansbury P.T. Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40 (2001) 7812-7819
104. Wang W. Protein aggregation and its inhibition in biopharmaceutics. Int. J. Pharm. 289 (2005) 1-30
105. Wang S.S., Good T.A., and Rymer D.L. The influence of phospholipid membranes on bovine calcitonin peptide's secondary structure and induced neurotoxic effects. Int. J. Biochem. Cell Biol. 37 (2005) 1656-1669
106. Wilson D.M., and Binder L.I. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am. J. Pathol. 150 (1997) 2181-2195
107. Wojtasek H., and Leal W.S. Conformational change in the pheromone-binding protein from Bombyx mori induced by pH and by interaction with membranes. J. Biol. Chem. 274 (1999) 30950-30956
108. Xiong L.W., Raymond L.D., Hayes S.F., Raymond G.J., and Caughey B. Conformational change, aggregation and fibril formation induced by detergent treatment of cellular prion protein. J. Neurochem. 79 (2001) 669-678
109. Yanagisawa K., Odaka A., Suzuki N., and Ihara Y. GM1 ganglioside-bound amyloid β-protein (Aβ): a possible form of preamyloid in Alzheimer's disease. Nat. Med. 11 (1995) 1062-1066
110. Yip C.M., Elton E.A., Darabie A.A., Morrison M.R., and McLaurin J. Cholesterol, a modulator of membrane-associated Aβ-fibrillogenesis and neurotoxicity. J. Mol. Biol. 311 (2001) 723-734
111. Yip C.M., Darabie A.A., and McLaurin J. Aβ-42-peptide assembly on lipid bilayers. J. Mol. Biol. 318 (2002) 97-107
112. Zerovnik E. Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. Eur. J. Biochem. 269 (2002) 3362-3371
113. Zerovnik E., Pompe-Novak M., Skarabot M., Ravnikar M., Musevic I., and Turk V. Human stefin B readily forms amyloid fibrils in vitro. Biochim. Biophys. Acta 1594 (2002) 1-5
114. Zhao H., Tuominen E.K.J., and Kinnunen P.K.J. Formation of amyloid fibers triggered by phosphatidylserine-containing membranes. Biochemistry 43 (2004) 10302-10307
115. Zhao H., Jutila A., Nurminen T., Wickstrom S.A., Keski-Oja J., and Kinnunen P.K.J. Binding of endostatin to phosphatidylserine-containing membranes and formation of amyloid-like fibers. Biochemistry 44 (2005) 2857-2863
116. Zhu M., Souillac P.O., Ionescu-Zanetti C., Carter S.A., and Fink A.L. Surface-catalyzed amyloid fibril formation. J. Biol. Chem. 277 (2002) 50914-50922
117. Zhu M., Li J., and Fink A.L. The association of α-synuclein with membranes affects bilayer structure, stability and fibril formation. J. Biol. Chem. 278 (2003) 40186-44097
118. Zhu M., Han S., Zhou F., Carter S.A., and Fink A.L. Annular oligomeric amyloid intermediates observed by in situ atomic force microscopy. J. Biol. Chem. 279 (2004) 24452-24459